Evaluation of non-instrumented nucleic acid amplification by loop-mediated isothermal amplification (NINA-LAMP) for the diagnosis of malaria in Northwest Ethiopia by Meslo Sema et al.
Sema et al. Malaria Journal  (2015) 14:44 
DOI 10.1186/s12936-015-0559-9RESEARCH Open AccessEvaluation of non-instrumented nucleic acid
amplification by loop-mediated isothermal
amplification (NINA-LAMP) for the diagnosis of
malaria in Northwest Ethiopia
Meslo Sema1*, Abebe Alemu2, Abebe Genetu Bayih3, Sisay Getie4, Gebeyaw Getnet4, Dylan Guelig5,
Robert Burton5, Paul LaBarre5 and Dylan R Pillai3,4Abstract
Background: Malaria is a major public health problem in sub-Saharan African countries including Ethiopia. Early
and accurate diagnosis followed by prompt and effective treatment is among the various tools available for prevention,
control and elimination of malaria. This study aimed to evaluate the performance of non-instrumented nucleic acid
amplification loop-mediated isothermal amplification (NINA-LAMP) compared to standard thick and thin film
microscopy and nested PCR as gold standard for the sensitive diagnosis of malaria in Northwest Ethiopia.
Methods: A cross-sectional study was conducted in North Gondar, Ethiopia from March to July 2014. Eighty-two
blood samples were collected from malaria suspected patients visiting Kola Diba Health Centre and analysed for
Plasmodium parasites by microscopy, NINA-LAMP and nested PCR. The NINA-LAMP method was performed using
the Loopamp™ Malaria Pan/Pf detection kits for detecting DNA of the genus Plasmodium and more specifically
Plasmodium falciparum using an electricity-free heater. Diagnostic accuracy outcome measures (analytical sensitivity,
specificity, predictive values, and Kappa scores) of NINA-LAMP and microscopy were compared to nested PCR.
Results: A total of 82 samples were tested in the primary analysis. Using nested PCR as reference, the sensitivity and
specificity of the primary NINA-LAMP assay were 96.8% (95% confidence interval (CI), 83.2% - 99.5%) and 84.3% (95% CI,
71.4% - 92.9%), respectively for detection of Plasmodium genus, and 100% (95% CI, 75.1% - 100%) and 81.2% (95% CI,
69.9% - 89.6%), respectively for detection of P. falciparum parasite. Microscopy demonstrated sensitivity and specificity
of 93.6% (95% CI, 78.5% - 99.0%) and 98.0% (95% CI, 89.5% - 99.7%), respectively for the detection of Plasmodium
parasites. Post-hoc repeat NINA-LAMP analysis showed improvement in diagnostic accuracy, which was comparable to
nested PCR performance and superior to microscopy for detection at both the Plasmodium genus level and
P. falciparum parasites.
Conclusion: NINA-LAMP is highly sensitive for the diagnosis of malaria and detection of Plasmodium
parasite infection at both the genus and species level when compared to nested PCR. NINA-LAMP is more
sensitive than microscopy for the detection of P. falciparum and differentiation from non-falciparum species
and may be a critical diagnostic modality in efforts to eradicate malaria from areas of low endemicity.* Correspondence: mesem2000@gmail.com
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Malaria is an infectious disease caused by protozoan par-
asites of the genus Plasmodium that continues to exact a
large human toll in endemic areas [1]. Although the in-
cidence and malaria specific mortality rate is declining
worldwide due to concerted global malaria control ef-
forts, malaria remains a major public health issue in
sub-Saharan African countries with occasional epidemics
leading to significant mortality. Children less than five
years of age and pregnant mothers bear the greatest bur-
den of illness [2-4].
Malaria contributes to 12% of outpatient consultations
and 10% hospital admissions in Ethiopia [5,6]. To reduce
this impact, the Ethiopian government is implementing
a five-year National Strategic Plan for Malaria Control
and Prevention, starting 2011. Achieving zero malaria
transmission in malarious areas and malaria elimination
in low transmission areas of the country are the two major
goals of the strategic plan. To achieve these goals, the
strategy calls for early and accurate diagnosis followed
by prompt treatment and case management of patients
with malaria [7,8].
Clinical diagnosis and parasitological confirmation by
microscopy using Giemsa-stained blood films (‘Giemsa
microscopy’) or rapid diagnostic test (RDT) are the mal-
aria diagnostic approaches currently employed throughout
Ethiopia. Giemsa microscopy is considered the gold stand-
ard and RDTs are alternatively used for the diagnosis of
malaria in all health facilities or through rural health ex-
tension and outreach. RDTs are relatively easier to per-
form and used for screening of malaria in remote areas
where electricity and other resources are limited [9,10].
However, microscopy and RDTs cannot reliably detect
lower-density parasitaemia (<100 parasites/μL) [11]. More-
over, microscopy requires experience and intensive training
on the part of the microscopist and needs careful prepar-
ation and application of reagents to ensure quality control
and assurance [12-14].
A recent study in Ethiopia showed that a high rate of
sub-microscopic Plasmodium parasite infection was de-
tectable by polymerase chain reaction (PCR) [15]. Another
study also showed that, compared to nested PCR, micros-
copy resulted in a high degree of misidentification and
misclassification of Plasmodium parasites in Ethiopia [16].
Similarly, the RDT methods reveal inconsistency of per-
formance (sensitivity, 20% to 99%) and stability problems
in rural health facilities where storage temperatures may
exceed 30°C [14].
Recently, nucleic acid amplification tests (NAATs) are
being considered as a point of care test (POCT) for diag-
nosis of malaria. These methods can detect the presence
of parasite in low-level infections which otherwise would
be missed by microscopy or RDT [17]. NAATs are used
for the detection of submicroscopic infections and toincrease the power of surveys at low transmission set-
tings [18]. Nested PCR is commonly used for malaria
epidemiological surveys with a detection limit of ~0.2
parasites/μL blood [19]. However, the method is prone
to contamination and reagents must be stored in cold
conditions to preserve function. The technique is also
sophisticated, requires training, capital investment and
expensive reagents. Therefore, PCR assays are less feas-
ible to be used as a POCT for malaria diagnosis in de-
veloping countries where malaria is endemic. Because of
its high sensitivity and specificity, PCR assays have rec-
ognized value in research settings and can serve as ref-
erence method in the evaluation of other diagnostic
methods [17,20].
Loop-mediated isothermal amplification (LAMP) can
amplify DNA/RNA with high specificity, efficiency and
rapidity under isothermal conditions. The method em-
ploys DNA polymerase and four or six primers recogniz-
ing distinct gene sequences targeting mitochondrial
DNA of the parasite. The method can detect parasit-
aemia as few as 5 parasites/μl of blood, below the detec-
tion limit of microscopy or RDT [21,22].
Numerous attempts have been made to develop sim-
plified molecular diagnostics for malaria appropriate for
low-resource or resource compromised settings [23,24].
PATH has recently developed a variety of non-
instrumented nucleic acid amplification (NINA) heater
configurations to facilitate pathogen detection via iso-
thermal nucleic acid amplification assays, such as
LAMP. The low-cost, electricity-free, reusable NINA
platform heater enables pathogen detection in low-
resource settings where there is no access to electricity
and/or instrumentation [25-28]. LAMP executed in a
NINA heater is rapid and simple and can be accom-
plished by minimally-trained health workers. Results can
be read simply by observing fluorescence or turbidity
visually in the reaction tube with no additional process-
ing [21,29,30].
In Ethiopia, availability of more rapid, easy, sensitive
and specific method of diagnosis is crucial to the success
of the National Strategic plan to eradicate malaria. The
diagnostic performance of LAMP has not yet been eval-
uated as a laboratory diagnosis tool in Ethiopia. This
study sought to examine the diagnostic performance of
NINA-LAMP compared to microscopy and nested PCR
for the diagnosis of malaria at Kola Diba Health Centre,
northwest Ethiopia.
Methods
Study design and study area
A cross-sectional diagnostic evaluation study was con-
ducted at Kola Diba Health Centre, Dembia District of
North Gondar administrative zone, northwest Ethiopia.
The district has an altitude range between 1,750 and
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is the most prevalent seasonal disease in the area and ac-
counts for the second most common reported disease in
the health centre. Plasmodium vivax, Plasmodium falcip-
arum and Plasmodium ovale are all reported in the area
[31,32]. Malaria clinical diagnosis is based on Giemsa mi-
croscopy in the health centre.
Study subjects and inclusion criteria
Study participants were recruited consecutively (con-
venient sampling) from malaria suspected febrile outpa-
tients based on self-reported history of fever within the
previous 24 hours and referred to the laboratory for mal-
aria testing using microscopy. Male and female febrile
patients of any age were enrolled in the study. Study par-
ticipants were not involved in the decision to be referred
to the laboratory or in any decision regarding clinical
management. Patients who had received anti-malarial
drugs during the past four weeks and critically ill pa-
tients were excluded from participation. Since the preva-
lence of malaria during data collection (March to April)
was very low, a total of 200 study participants were
recruited to increase the number of positive cases for
assuring the reliability of diagnostic test evaluation. All
microscopy positives (30) and 52 negatives from a total
170 negatives were included in the study. The 52 nega-
tives were selected by identifying one in every three (ap-
proximately) microscopy negative patients for molecular
testing by NINA-LAMP and nested PCR.
Blood collection and microscopic diagnosis of malaria
Capillary blood was taken from 200 study participants,
and both thick and thin blood film was prepared on a
slide for microscopic detection of Plasmodium parasites.
After air-drying, the thin blood films were fixed in
methanol. Thin and thick blood films were stained with
10% Giemsa solution for 10 min and examined by experi-
enced laboratory personnel using manual for laboratory
diagnosis of malaria in Ethiopia (2012). The presence of
Plasmodium infection was ruled out if no parasites were
observed after examining at least 100 microscopic fields
with 100X objective. Parasitaemia was estimated by count-
ing the number of parasites per 200 white blood cells in a
thick blood film and then calculated as parasite count per
microlitre by assuming a total specimen white blood cell
count of 8,000/μl [33].
Giemsa microscopy was performed by two experi-
enced laboratory technicians and verified by a study-
blinded third expert to resolve any discordance between
the two readers. The reported parasite density is the
average of the two laboratory personnel’s parasite count.
If more than 10% discrepancy was observed between the
two readers parasite count, the third expert blindly
counted parasite load and recorded as correct result.Sample collection for molecular analysis
Approximately four millilitres of venous blood was drawn
from 82 microscopically confirmed study participants
(30 positives and 52 negatives participants). Soon after
collection, two separate drops of blood were placed on
Whatman filter paper 903 (GE Healthcare) and air dried
individually to avoid any chance of contamination. The
remaining blood was dispensed into 5 ml tubes contain-
ing 0.08 ml of 10% ethylenediaminetetraacetic acid
(EDTA) solution and stored at 2-8°C in Kola Diba health
centre up to four days. The patient code and date of col-
lection were recorded on filter paper and EDTA tube.
Samples collected at the health centre were transported
once a week to the University of Gondar laboratory on
ice. Upon arrival, venous blood samples were stored
in −80°C freezer for subsequent LAMP analysis. The
dried filter papers were individually inserted into small
zip locked plastic bags and packed within a larger plastic
bag for transportation to University of Calgary, Canada
for nested PCR analysis.
Malaria LAMP assay using NINA
The LAMP assay used in this study utilize primers for
amplification of parasite mitochondrial DNA. Loopamp™
malaria Pan/Pf detection kits (Eiken Chemicals, Tokyo,
Japan) consisting of plastic reaction tubes containing
thermostable vacuum-dried reagents used to amplify
Plasmodium/ P. falciparum DNA. The parasite DNA
was extracted by a boil and spin method as follows. Sixty
μL of EDTA blood was added to 60 μL of extraction so-
lution (400 mM NaCl, 40 mM Tris pH 6.5, and 0.4% so-
dium dodecyl sulfate) in an Eppendorf tube, heated for
5 minutes at 95°C with a water bath, and centrifuged at
10,000 × g for 3 minute; 30 μL of the clear supernatant
was pipetted into a dilution tube containing 345 μl ster-
ile water. Then, 30 μl of diluted DNA sample was dis-
pensed into the reaction tube and mixed well with
reagent for use in the NINA-LAMP assay.
The NINA H.V6 prototype heater was used to produce
isothermal conditions suitable for LAMP procedure,
after which the tubes were removed and analysed. The
NINA device operation was performed following the
prototype manual provided by PATH (Seattle, USA). An
exothermic chemical reaction coupled with a phase-
change material (PCM) provides temperature control to
the NINA device (Figure 1). To activate the heater, 5 mL
0.9% saline (Medline Industries Inc, USA) is combined
with 0.9 g MgFe fuel pack, provided by PATH inside of
the thermos cup. Post-activation, the device requires ap-
proximately 15 minutes for reaching isothermal condi-
tions of amplification after initiation of exothermic
reaction and maintains 64 ± 1°C for 60 minutes. DaqPRO
5300 data recorder containing instrumented PCR tubes
was used to measure and record temperature profile of
Figure 1 Photograph and cross sectional view of the NINA H.V6 prototype heater device. The reusable-housing platform is designed to
heat micro PCR tubes using a commercial thermos with manufactured inserts. Five sample wells are surrounded by the phase change material
(PCM) chamber and the exothermic reaction takes place below the PCM at the bottom of the stainless-steel insulated thermos. The PCM is used
to buffer the exothermic reaction and provide a constant temperature to the sample wells. Disposable magnesium iron alloy (MgFe) and saline
cartridges can be simply dropped into the housing to activate the device.
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ple and reagent were inserted into HV6 thermos to be
amplified after checking the internal temperature (63–65°C).
After 40 minutes of amplification, the reaction tubes were re-
moved from device. The LAMP reaction produces insoluble
magnesium orthophosphate as a by-product of DNA amplifi-
cation, which is detected visually as turbidity immediately
post-reaction.
The NINA-LAMP assay was conducted by one labora-
tory technician following adequate training in the test pro-
cedure. Sample processing and LAMP result interpretation
were performed following standard protocols determined
previously by the Foundation for Innovative New Diagnos-
tics (FIND) [34]. To avoid cross-contamination, three sep-
arate rooms were use to perform DNA extraction, mixing
of reagents and sample, and amplification using standard
one-way workflow. Upon completion of the reaction,
LAMP amplification test results were read and interpreted
by observing turbidity using positive and negative control
results as comparator standards. Two additional study-
blinded laboratory technicians read the turbidity observed
at the end of the LAMP reaction and the consensus was
regarded as the correct interpretation of LAMP result. La-
boratory personnel performing the LAMP assay were
blinded to any result of Giemsa microscopy and nested
PCR during the course of the study.
Nested PCR- based detection of Plasmodium parasites
Genomic DNA was extracted from dried blood on
Whatman filter paper 903 (GE Healthcare). Two six
millimetre diameter blood containing filter paper con-
fetti were cut from each sample using a paper puncher
and transferred into a microtube. To prevent sample
cross-contamination, the puncher was cleaned with 70%ethanol, sterilized using the flame of a Bunsen burner
and two confettis were cut from a new filter paper before
taking the next sample. Genomic DNA was extracted
using Quick-gDNA™ Blood MiniPrep kit (Zymo research
corp., USA). The procedure on the company’s instruction
manual was followed with slight modification. Briefly, the
blood spot confetti were treated with 200 μl of genomic
lysis buffer for 30 minutes with quick vortex every five mi-
nutes. The DNA in the buffer was then transferred into
Zymo-Spin™ IIC Column in a collection tube, washed with
wash buffer and eluted with 40 μl of sterile distilled water.
Nested PCR was performed following previously pub-
lished procedures with slight modification [35,36]. The
small subunit ribosomal RNA gene was amplified using
genus-specific primers (rPLU5 and rPLU6). Then, the
PCR product was diluted 1:5 in sterile distilled water.
The second PCR was done from the diluted PCR product
in four separate tubes using species-specific primers;
rFAL1/rFAL2, rVIV1/rVIV2, rOVA1/OVA2, rMAL1/
rMAL2, for P. falciparum, P. vivax, P. ovale, and Plasmo-
dium malariae, respectively. The PCR mixture contained
1X standard Taq buffer, 125 nmol dNTPs, 2.5 μM MgCl2,
250nMol of each of the forward and reverse primers, 0.4U
Taq DNA polymerase, sterile distilled water, and template
DNA in a total volume of 20 μl. All the reagents were pur-
chased from New England BioLabs® Inc. (Whitby, ON).
The first and second PCR reactions were carried out using
5 μl of the genomic DNA and 2 μl of the diluted first PCR
product, respectively. The PCR program for the first PCR
involved one cycle of 95°C for 3 min, 58°C for 2 min, 68°C
for 2 min followed by 24 cycles of denaturation at 94°C
for 1 min, annealing at 58°C for 2 min, and extension at
68°C for 2 min and a final cycle of 58°C for 2 min and
68°C for 5 min. The second PCR was run with the same
Table 1 NINA- LAMP result compared with Giemsa-stained
microscopy and nested PCR for the detection of
Plasmodium parasite in 82 patient samples at Kola Diba
health centre, Northwest Ethiopia, 2014
Giemsa microscopy (n) Primary NINA- LAMP
result (n)
Nested PCR (n)
Positives (30), Positives (38), Positives (31),
P. falciparum (13) P. falciparum (26) P. falciparum (13)
P.vivax (17) Non- P. falciparum (12) P. vivax (11), P. ovale (7)
Negatives (52) Negatives (44) Negatives (51)
n = number of blood samples examined; NINA = Non-instrumented nucleic
acid amplification; LAMP = Loop-mediated isothermal amplification; nested
PCR = nested polymerase chain reaction.
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run on a 2% agarose gel and visualized using a Gel Doc™
(Bio-Rad, Mississauga, ON).
Data analysis
After assuring data completeness, data were analysed by
SPSS version 20 and MedCalc easy to use online statis-
tical software version 13.3 used for diagnostic test evalu-
ation. Sensitivity, specificity, and positive and negative
predictive values of NINA- LAMP and Giemsa micros-
copy were determined using nested PCR as the gold
standard for diagnosis of malaria. The concordance re-
sponse rate (percentage of responses with both positive
and both negative results) and Kappa value (k) was de-
termined to measure degree of agreements between two
diagnostic test results. Secondary analysis (repeat testing
from original samples) was performed at University of
Calgary for samples which the original nested PCR and
malaria NINA-LAMP results disagreed.
Ethical consideration
The study protocol was reviewed and approved by
Research and Ethical Review Committee of School of
Biomedical and Laboratory Sciences, College of Medicine
and Health Sciences, University of Gondar (SBLS; refer-
ence No 525/06). Permission to conduct the study was
also obtained from Dembia district health bureau. All
study participants signed written informed consent be-
fore enrollment. Patients found to be positive for malaria
parasite were treated according to the current treatment
guideline for malaria in the country.
Results
Parasite positivity by Giemsa microscopy and NINA-LAMP
and nested PCR
Giemsa microscopy for 200 febrile malaria suspected pa-
tients resulted in 15.0% (30/200) confirmed positive for
Plasmodium parasites with a median parasite density of
9,800 parasites/μL (parasitaemia range = 420–186,800
parasites/μL). Of those positives, 43.3% (13/30) and
56.7% (17/30) had P. falciparum and P. vivax infection,
respectively. Mixed infection with Plasmodium species
was not identified by microscopy. From the total of 200
study participants, samples of 82 patients (30 positives
and 52 negatives) were analysed by NINA-LAMP and
nested PCR methods. During primary analysis, NINA-
LAMP method identified 38 positives from total 82 sam-
ples performed in Gondar using Loopamp™ malaria Pan
Detection kits (46.3%). From those positives by NINA-
LAMP, 68.4% (26/38) tested positive for P. falciparum
using Loopamp™ malaria Pf detection kits. The nested
PCR analysis performed using four Plasmodium species
primers detected 31 positives for Plasmodium parasitesfrom 82 patient samples analysed. Of those positives,
41.9% (13/31), 35.5% (11/31) and 22.6% (7/31) were due
to P. falciparum, P.vivax and P. ovale, respectively. All
P. ovale positive samples diagnosed by nested PCR were
misclassified as P vivax by microscopy. Table 1 presents
the parasite positivity by Giemsa microscopy, NINA-
LAMP and nested PCR for the diagnosis of Plasmo-
dium parasites.Discordant analysis of microscopy, NINA-LAMP and
nested PCR for diagnosis of Plasmodium parasites
During primary NINA-LAMP analysis in Gondar, false
positives were observed in detecting both genus Plasmo-
dium and P. falciparum. Discordant results were observed
from ten patient samples using the three diagnostic tests
for detecting Plasmodium parasites in Gondar. The NINA-
LAMP method identified eight patient samples as positive
for Plasmodium parasites, which were classified as nega-
tive by microscopy. Nested PCR detected one positive and
seven negative from those discordant results by NINA-
LAMP and Giemsa microscopy. Additionally, one sample
was identified as positive by nested PCR from previously
negative samples by microscopy and NINA–LAMP.
Nested PCR also detected one negative result from other
positive sample by Giemsa microscopy and NINA-LAMP.
The NINA-LAMP method detected 13 additional positive
samples for P. falciparum using nested PCR as reference
method (Table 2). In post hoc analysis, nested PCR and
NINA-LAMP discordant samples were retested in a con-
trolled laboratory setting in the University of Calgary,
Canada. Specifically, NINA-LAMP was repeated for four-
teen samples to detect Plasmodium genus and/or P. fal-
ciparum. All samples with primary positive results in
Gondar were subsequently identified as NINA-LAMP
negative for Plasmodium genus and P. falciparum. After
NINA-LAMP repeat testing, only results of two samples
were discordant with results of nested PCR for detecting
genus Plasmodium (Table 2).
Table 2 Discordant analysis of microscopy, NINA-LAMP and nested PCR for detection of Plasmodium parasite at Kola















Primary analysis in Gondar for pan (n) 7 1 1 1 43
Primary analysis in Gondar for Pf (n) 13 0 0 1 56
Repeat testing in Calgary for pan (n) 0 1 1 1 50
Repeat testing in Calgary for Pf (n) 0 0 0 1 69
(−) means negative result, (+) means positive result, n = number of patient samples.
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as compared to nested PCR for diagnosis of malaria
During primary analysis in Gondar, Ethiopia, the LAMP
assay had a sensitivity and specificity of 96.8% and 84.3%
respectively compared with the nested PCR method.
Using Bayesian analysis, the positive and negative predictive
values of NINA-LAMP for detecting Plasmodium parasites
were 52.1% and 99.3%, respectively. The NINA-LAMP re-
sult had also substantial agreement (κ = 0.776) with results
of nested PCR for detection of Plasmodium parasites. For
the diagnosis of P. falciparum, the sensitivity and specifi-
city of NINA-LAMP was 100% and 81.2%, respectively.
The corresponding positive and negative predictive values
were 27.0% and 100%, respectively. In this study, NINA-
LAMP assay and nested PCR showed moderate agreement
(κ = 0.577) for identification of P. falciparum parasite.
In a controlled laboratory setting in Calgary, Canada,
the NINA-LAMP method showed improvements in diag-
nostic accuracy using nested PCR as reference method.
The sensitivity, specificity, PPV and NPV of NINA-LAMP
for detecting Plasmodium parasites were 96.8%, 98.0%,
89.7% and 99.4%, respectively. The NINA-LAMP result
had almost perfect agreement (κ =0.948) with results of
nested PCR for detection of Plasmodium parasites. The
secondary NINA-LAMP test result was also 100% con-
cordant (sensitivity, specificity, PPV and NPV of 100%)
with nested PCR for detection of P. falciparum.
The sensitivity, specificity, PPV, and NPV of micros-
copy were 93.6%, 98.0%, 89.4% and 98.8% respectivelyTable 3 Diagnostic accuracy of NINA-LAMP and microscopy c
of Plasmodium parasite and P. falciparum at Kola Diba Health
Method Senstivity(%) (95% CI) Specificity(%) (95%
NINA -LAMP Pan (Gondar) 96.8 (83.2-99.5) 84.3 (71.4-92.9)
Pf (Gondar) 100 (75.1-100) 81.2 (69.9-89.6)
Pan (Calgary) 96.8 (83.2-99.5) 98.0 (89.5-99.7)
Pf (Calgary) 100 (75.1-100) 100 (94.7-100)
Microscopy Pan 93.6 (78.5-99.0) 98.0 (89.5- 99.7)
Pf 92.3 (63.9-98.7) 100 (94.7-100 )
Percentage of agreement between tests: (Number of positives by both tests + Num
Kappa value(κ): 1.00 = Perfect agreement; > 0.80, almost perfect agreement; 0.61-0.8
agreement; NPV = negative predictive value; PPV = positive predictive value; Pan = P
confidence interval.compared with nested PCR for the diagnosis of Plasmo-
dium parasites. The microscopy data agreed well (96.3%)
with the nested PCR results. For the detection of P. fal-
ciparum, microscopy also demonstrated sensitivity, spe-
cificity, PPV and NPV of 92.3%, 100%, 100% and 99.5%,
respectively. Table 3 presents sensitivity, specificity,
negative predictive value, positive predictive value and
Kappa value for NINA-LAMP assay and microscopy as
compared to nested PCR for detection of genus Plas-
modium and P. falciparum parasite.
Discussion
Early and accurate diagnosis of malaria in health service
facilities is required for prompt treatment and case
management of malaria [9,10]. Routine diagnostic methods
such as microscopy and RDT cannot detect low-density
Plasmodium infections and have a number of practical
limitations [11-14]. NAAT methods like LAMP have been
developed and evaluated for diagnosis of malaria in differ-
ent parts of the world. LAMP utility is enhanced by NINA
as no major capital equipment or electricity is required to
perform the reaction [26-28]. Performance evaluation of
LAMP was conducted in different settings using nested
PCR and/or microscopy as reference methods. Previous
findings suggest that this molecular diagnostic kit would
be used as point of care for detection of malaria [17,37].
The NINA- LAMP assay used pan–Plasmodium genus
specific primers and P. falciparum specific primers. The
pan–Plasmodium genus specific primers were used toompared with the gold standard nested PCR for diagnosis
Centre, Northwest Ethiopia, 2014
CI) PPV(%) (95% CI) NPV(%) (95% CI) %agreement (Kapp = κ)
52.1 (33.9-71.3) 99.3 (96.0-99.9) 89.0 (0.776)
27.0 (14.8-40.0) 100 (97.6-100) 84.1 (0.577)
89.7 (58.3-98.2) 99.4 (96.8-99.9) 97.6 (0.948)
100 (49.8-100) 100 (98.2-100) 100 (1.000)
89.4 (56.9-98.2) 98.8 (95.9-99.8) 96.3 (0.922)
100 (45.8-100) 99.5 (97.4-99.9) 98.8 (0.953)
ber of negatives by both tests)/N, against what might be expected by chance;
, substantial agreement; 0.41-0.6, moderate agreement; 0.21-0.4, fair
lasmodium genus; Pf = Plasmodium falciparum; 95% CI = 95%
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drial DNA of Plasmodium genus in samples of symp-
tomatic patients. This NINA-LAMP evaluation showed
good diagnostic accuracy for the diagnosis of malaria as
compared to nested PCR, which satisfies the WHO rec-
ommendation that requires diagnostic kits sensitivity of
greater than 95%. The LAMP performed in the NINA
heater achieved diagnostic accuracy comparable to other
LAMP evaluation studies conducted using nested PCR
as the reference method. For example, using Plasmo-
dium genus specific primers, LAMP showed sensitivity
and specificity of 97.0%, 99.2%, respectively from sam-
ples extracted by PURE method in a UK parasitology
reference laboratory for returning travellers [38]. The
LAMP assay performed at remote clinic in Uganda using
samples extracted by boil and spins method showed al-
most comparable sensitivity (93.9%) and lower specificity
(76.3%) than the present study [39]. Furthermore, in Re-
public of São Tomé and Príncipe, LAMP demonstrated
100% sensitivity and 98% specificity for diagnosis of
Plasmodium parasites before treatment using nested
PCR as reference method [40]. Thus, the present study
was in line with the diagnostic accuracy of LAMP reported
in the previous studies.
For rapid case management and treatment of patients
with malaria, confirming the presence of potentially fatal
falciparum malaria is necessary. Loopamp™ Malaria Pf
detection kits containing P falciparum primers were
used to confirm the presence of this species. For the
diagnosis of P. falciparum, the present NINA-LAMP
method results were similar with diagnostic sensitivity of
LAMP reported in Northern Thailand (sensitivity = 100%)
and the UK reference laboratory (sensitivity = 98.4%)
[38,41]. This study also showed far higher diagnostic sensi-
tivity of LAMP than sensitivity reported in Bangladeshi
in-patients with fever (sensitivity =76.1%) [42].
The diagnostic accuracy of LAMP in a secondary la-
boratory analysis was higher than the primary field
analysis. The possible reason may arise from sample
contamination during primary analysis. Primary ana-
lysis was performed on site in Gondar with limited la-
boratory materials and resources while secondary
analysis was performed at University of Calgary with
direct access to substantial laboratory resources. Due
to limited resources, non-filter tips were used to trans-
fer samples and reagents in Gondar, leading to sus-
pected aspirate contamination of the pipettes. The boil
and spin method of DNA extraction was performed in
an open system which contributes to possible risks of
contamination during sample processing in Gondar.
As a result, false amplification in the negative control
tube was observed in some LAMP tests during primary
analysis. Simple remedial actions were taken in the
form of repeated sterilization of tools and regents, andproper cleaning of work areas until false amplification
in the negative control was eliminated. This suggests
that temporary laboratory contamination occurred and
may have resulted in the observed discordance be-
tween primary and secondary LAMP testing. Further-
more, no contamination issues arose from filter paper
samples evaluated by LAMP in Calgary. Filter papers
were split off and sent to Calgary prior to any possibil-
ity of end product contamination in Gondar.
A recent study in northwest Ethiopia showed that
nested PCR is more effective in detecting Plasmodium
in suspected malaria patients than microscopy. It detected
13.1% (39/297) positives which had been confirmed nega-
tive by Giemsa microscopy. This high rate of misidentifi-
cation by microscopy was associated with the difference in
detection limit of the two methods, and skills and experi-
ences of microscopists to detect and identify Plasmodium
parasites [16]. Giemsa microscopy could not detect para-
site densities below 100 parasites/μl of blood while nested
PCR had the ability to detect Plasmodium parasitaemia as
few as one parasite/μl of blood [11,19]. The LAMP
method had a similar detection threshold with nested
PCR [22]. In this study, malaria NINA-LAMP demon-
strated diagnostic sensitivity similar to that of nested PCR
and superior to that of microscopy. Therefore, the NINA-
LAMP method could be a practical alternative to PCR
method to avoid misidentification of malaria by micros-
copy in endemic areas and detection of submicroscopic
infections in low transmission settings.
The method relied on isothermal amplification in a
NINA heater, which permits POCT in low resource set-
tings. The NINA enabled electricity free reaction condi-
tions comparable to a thermocycler or water bath. The
NINA-LAMP test procedure used in this study did not
require special equipment and can be used in remote
malaria endemic areas. The test procedure was also done
with short-term training and no previous experience.
Negative and positive controls were used for interpret-
ation of sample test results. For running one batch of
five tests, the whole test procedure took 60–80 minutes.
Considering the advantages of rapid amplification, sim-
ple operation and easy detection, NINA-LAMP has po-
tential applications for clinical diagnosis and surveillance
of malaria in developing countries including Ethiopia
without requiring electricity, sophisticated equipment or
skilled personnel. Limitations of this study include the
use of microscopy for case detection and the possible
bias that may introduce, and also the failure to obtain
“asymptomatic” or low parasitemia cases. Furthermore,
sample preparation still requires a centrifugation step.
The NINA-LAMP method was performed in three
separate steps namely DNA extraction, addition to the
LAMP reaction tube, followed by NINA-based amplifi-
cation. Combining the three steps may reduce cost,
Sema et al. Malaria Journal  (2015) 14:44 Page 8 of 9turnaround time, and possible risk of contamination.
This study relied on commercially available LAMP kits
from Eiken Chemicals, Japan and a NINA instrument
from PATH, USA. Modification of this NINA prototype
to include direct sample addition could simplify the pro-
cedure and eliminate contamination risk for the diagno-
sis of malaria in remote low-resource settings.
In conclusion, NINA-LAMP performed well in com-
parison to nested PCR for the diagnosis of malaria sus-
pected febrile patients in Ethiopia. NINA-LAMP was
highly sensitive for detection of Plasmodium parasites.
The method was simple and experience was not re-
quired to perform the test procedure. The result of the
test was also easy to read and interpret as compared to
routine diagnostic method by Giemsa microscopy. The
lyophilized reagents were thermostable. Future studies
will aim to evaluate the potential for NINA-LAMP to
detect asymptomatic or low parasitemia cases missed by
microscopy, a central focus of the National Control
Programme in the next decade.
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